Real-world supplement studies are inherently limited by confounding and lack of controls; clinicians should not recommend ACEMg for sensorineural hearing loss based on this evidence alone and should await controlled trial data.

Dietary supplement use is common among hearing loss patients, and real-world data on ACEMg efficacy (or lack thereof) can inform counseling and help set patient expectations.

1. 01Study investigates ACEMg supplementation in adults with sensorineural hearing loss.
2. 02Real-world design limits causal conclusions due to lack of a controlled comparator.